NASDAQ : DRUG

Bright Minds Biosciences Inc. — Earnings Estimates

$73.26 USD

-$1.37 (-1.84%)

Volume
212.58K
Average Volume
318.93K
Market Capitalization
$717.01M
P/E Ratio
-30.42
Dividend Yield
0.00%
Price Target
$145.00
Year High
$123.75
Year Low
$32.50
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$81.48

Annual earnings financials

DRUG financial data with annual/quarterly toggle

DRUG GAAP EPS - Annual & Quarterly

DRUG Sales Revenue - Annual & Quarterly

DRUG Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

DRUG Estimated and Actual Revenue by Quarter
DRUG Estimated and Actual EPS by Quarter
DRUG Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
DRUG Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-09-30 0 -34.64M -34.64M -34.64M - - -
2027-06-30 0 -31.04M -31.04M -31.04M - - -
2027-03-31 0 -30.54M -30.54M -30.54M - - -
2026-12-31 0 -26.16M -26.16M -26.16M - - -
2026-09-30 0 -29.92M -17.28M -23.6M - - -
2026-06-30 0 -22.77M -12.2M -17.49M - - -
DRUG Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-09-30 0 - - - 1 -3.61232 -3.61232 -3.61232
2027-06-30 0 - - - 1 -3.23634 -3.23634 -3.23634
2027-03-31 0 - - - 2 -3.18462 -3.18462 -3.18462
2026-12-31 0 - - - 2 -2.72824 -2.72824 -2.72824
2026-09-30 0 - - - 4 -3.1198 -1.80195 -2.46088
2026-06-30 0 - - - 4 -2.37436 -1.27245 -1.8234